Skip Navigation

Pharmacy Residency Program

  • pharmacy clean room

    The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related disease.

    The Pharmacy department maintains programs and practices to ensure safe, optimal, and cost effective drug therapy for Dana-Farber patients, while also supporting patient and provider drug education and patient care-oriented research.

  • About the Pharmacy Residency Program

    Dana-Farber Cancer Institute is proud to offer two ASHP-accredited Post-Graduate Year 2 (PGY-2) Pharmacy Residency Programs:

    • Oncology Pharmacy Residency (Onc) – 2 positions
    • Pain Management/Palliative Care Pharmacy Residency (PMPC) – 1 position

    These positions are designed to provide the resident with opportunities to develop clinical competence in pharmacy practice. Residents are exposed to a multitude of experiences related to patient care, involving both inpatient care and ambulatory-related experiences.

    Pharmacy resident benefits

    Pharmacy residents will receive a competitive stipend for the PGY-2 residency year. Other benefits include, but are not limited to, medical and dental coverage, and MBTA discount passes. In addition, there is conference fee and travel compensation available for residents to attend up to 2 national and 2 local conferences, including the ASHP Mid-Year Meeting.

    Holidays

    New Year’s Day, Martin Luther King Day, President’s Day, Memorial Day, Independence Day, Labor Day, Columbus Day, Thanksgiving Day, and Christmas Day are all observed holidays.

    Vacation days

    Residents are entitled to 10 days of vacation. Vacation days are to be approved by the residency director and sufficient notice given.

  • Oncology Pharmacy Residency (Onc)

    Residents in the Oncology Pharmacy Residency will gain experience in the following areas of practice:

    • Adult ambulatory oncology
    • Inpatient medical and hematologic oncology
    • Inpatient stem cell transplant
    • Palliative care
    • Pediatric oncology
    • Medication safety
    • Investigational drug services
    • Grand rounds, tumor board, and other oncology-related lectures

    Through these educational experiences, residents will:

    • Demonstrate development as a role model for clinical pharmacists in the oncology setting.
    • Develop various teaching styles for application in a variety of settings, including experiential education, small group teaching, and group lecture.
    • Collaborate with clinical pharmacy staff to provide educational resources for patients and practitioners.
    • Develop skills in pharmacy administration, disease state management, drug information, synthesis and analysis of clinical information, and development of clinical care plans.
    • Refine communication and time management skills.
    • Develop, implement, and analyze data of a year-long, publishable research project.
    • Incorporate self-directed learning and personal development through self-reflection, evaluation, and feedback.

    Dana-Farber’s PGY-2 Oncology Pharmacy Residency gives residents many opportunities to co-precept and lecture students at the affiliated schools of pharmacy. The residency is primarily affiliated with two schools of pharmacy, including Northeastern School of Pharmacy and MCPHS University-Boston.

    Research projects

    Research projects will be determined according to the resident's interest and departmental needs. The resident will be required to complete one project to be presented at a national meeting, such as at the HOPA (Hematology/Oncology Pharmacy Association) annual conference. The resident will also prepare a finished manuscript suitable for publication by the end of the residency year.

    Examples of past resident research projects include:

    • Differentiation Syndrome in Patients Based on Timing of Initial All-Trans Retinoic Acid Administration (accepted ASH poster presentation, 2017)
    • Evaluation of Thromboembolic Events in Patients Receiving Direct Oral Anticoagulation Therapy (accepted ASH poster presentation, 2017)
    • Characterization and assessment of anti-cancer therapy used to treat elderly patients with gynecologic malignancies
    • Characteristics of hematopoietic stem cell transplant patients who fall
    • Pharmacist-managed counseling for patients who are discharged after hematopoietic stem cell transplant

    Oncology Pharmacy Learning Experiences

    Core Learning Experiences

    • Orientation (2 weeks)
    • Oncology Infusion Pharmacy (5 weeks)
    • Ambulatory oncology (6 weeks)
    • Medical oncology (4 weeks)
    • Hematologic oncology (6 weeks)
    • Palliative care unit (6 weeks)
    • Stem cell transplant (5 weeks)
    • Pediatric oncology (4 weeks)
    • Investigational drug service (4 weeks)

    Longitudinal Learning Experiences

    • Medication safety (6 months)
    • Pharmacy administration (10 months)
    • Weekly Oncology Topic Discussions (12 months)
    • Academia (10 months) (Certificate programs available for those interested)

    Elective Learning Experience Opportunities

    • Medical Oncology II
    • Hematologic Oncology II
    • Ambulatory Oncology II
    • Palliative Care II
  • Pain Management/Palliative Care Pharmacy Residency (PMPC)

    The Dana-Farber Cancer Institute PGY-2 Pain Management and Palliative Care Pharmacy Residency is designed to provide the resident with opportunities to develop clinical competence in pain management and palliative care in various settings.

    The PGY-2 Pain Management and Palliative Care Pharmacy resident will gain experience in the following areas of practice: inpatient and outpatient palliative care, hospice, inpatient and outpatient specialized pain management, and pain management in the primary care setting. Primary rotation sites include: Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and MCPHS University.

    Didactic and experiential learning is enhanced through the Harvard Interprofessional Palliative Care Fellowship Program, which provides the only opportunity nationally for a pharmacy resident to join a fellowship with medical, nursing, and social work fellows in both adult and pediatric palliative care. The pharmacy resident is fully integrated into this fellowship program, which offers didactic and experiential learning geared toward the health care professional working with an interdisciplinary team.

    Throughout these experiences a resident completing the program will be able to:

    • Demonstrate development as a role model for clinical pharmacists in the pain management and palliative care setting.
    • Develop various teaching styles and approaches for application in a variety of settings, including experiential education, small group teaching, and group lecture.
    • Collaborate with clinical pharmacy staff to provide educational resources for patients and practitioners.
    • Develop skills in the areas of pharmacy administration, disease state management, drug information, synthesis and analysis of clinical information, and development of clinical care plans.
    • Refine communication and time management skills.
    • Develop, implement and analyze data of a yearlong, publishable research project.
    • Incorporate self-directed learning and personal development through self-reflection, evaluation, and feedback.

    Pain Management/Palliative Care Learning Experiences

    Core Clinical Learning Experiences

    • Orientation (2 weeks)
    • Intensive Palliative Care Unit (6 weeks)
    • Hospice (4 weeks)
    • Inpatient Palliative Care Consult Team (6 weeks)
    • Ambulatory pain management (12 weeks)
    • Academia (12 weeks concurrent with Ambulatory Pain Management)
    • Post-Operative Pain Management Service (2 weeks)

    Longitudinal Learning Experiences

    • Outpatient Palliative Care Clinic (16 weeks)
    • Harvard Interprofessional Palliative Care Fellowship (12 months)
    • Residency Project (past project example: Improving Accuracy of PCA Documentation in EPIC at MGH)
    • Outpatient Pharmacy Department (12 months)

    Elective Learning Experience Opportunities

    • Palliative Care Clinic II
    • Hospice II
    • Palliative Care Consult II
    • Intensive Palliative Care Unit II
  • Residency Director

    Bridget Fowler Scullion, PharmD, BCOP
    Clinical Pharmacy Manager
    Education: St. Louis College of Pharmacy
    Palliative Care Residency: University of Maryland, School of Pharmacy, Baltimore, MD
    Director: Oncology Pharmacy Residency, Pain Management & Palliative Care Pharmacy Residency
    Precepts: Outpatient Palliative Care, Inpatient Palliative Care Consults, Harvard Interprofessional Palliative Care Fellowship, Residency Project (PMPC)

    Residency Program Coordinator

    Hillary A. Prescott, PharmD
    Manager, Clinical Pharmacy Services
    Clinical Specialist, Lymphoma
    Education: University of Rhode Island, Providence, RI
    PGY-1: Virginia Commonwealth University Health System/Medical College of Virginia Hospitals, Richmond, VA
    PGY-2 Oncology Pharmacy: University of North Carolina Hospitals, Chapel Hill, NC
    Precepts: Ambulatory Oncology

    Preceptors

    Sylvia B. Bartel, RPh, MHP
    Vice President of Pharmacy Services
    Education: University of Wisconsin, Madison, WI
    PGY-1: National Institutes of Health, Clinical Center, Bethesda, MD
    Precepts: Administration (Onc)

    Christy S. Harris, PharmD, BCPS, BCOP
    Associate Professor, MCPHS University, Clinical Pharmacy Specialist
    Education: University of Tennessee Health Sciences, Memphis, TN
    PGY-1: University of Tennessee Medical Center, Knoxville, TN
    PGY-2 Oncology: Medical University of South Carolina, Charleston, SC
    Precepts: Academia (Onc)

    Michele Matthews, PharmD, CPE, BCACP, FASHP
    Associate Professor of Pharmacy Practice, MCPHS University
    Advance Practice Pharmacist, Pain Management, Brigham and Women's Hospital, Boston, MA
    Education: MCPHS University, Boston, MA
    PGY-1: Robert Wood Johnson Hospital, New Brunswick, NJ
    Precepts: Ambulatory Pain Management (PMPC), Academia (PMPC)

    Anne McDonnell, PharmD, BCOP
    Inpatient Oncology Pharmacy Specialist
    BS: MCPHS University, Boston
    PharmD: University of Arkansas for Medical Sciences
    PGY-1: New York Presbyterian Hospital, New York, NY
    PGY-2 Oncology: Medical University of South Carolina, Charleston, SC
    Precepts: Hematologic Malignancies

    Michelle An, PharmD
    Inpatient Oncology Pharmacy Specialist
    Education: University of Michigan, Ann Arbor, MI
    PGY-1: Scripps Mercy Hospital, San Diego, CA
    Precepts: Bone Marrow Transplant

    Houry Leblebjian, PharmD, BCOP
    Clinical Pharmacy Practice Administrator
    Education: Lebanese American University, West Beirut, Lebanon
    PGY-1: UMass Memorial Medical Center, Worcester, MA
    PGY-2 Oncology: Dana-Farber Cancer Institute, Boston, MA
    Precepts: Ambulatory Oncology (Onc)

    James Krasnow, BS, MS, RPH
    Consultant Pharmacist, Visiting Nurses Association of Boston-Hospice
    BSPharm, Northeastern University, Boston, MA
    Masters, Tufts University, Pain Research, Education, and Policy, Boston, MA
    Precepts: Hospice (PMPC)

    Laura Cedro, PharmD, MPH
    Investigational Drug Services Charge Pharmacist
    Pharmacy Education: Northeastern University, Bouve College of Health Sciences, Boston, MA
    MPH: Harvard T.H. Chan School of Public Health, Boston, MA
    Precepts: Investigational Drug Services

    Andrew Skirvin, BS, PharmD, BCOP
    Associate Clinical Professor, Northeastern University, Hematology/Oncology Clinical Pharmacist
    Education: University of Texas Health Science Center (PharmD) and Oregon State University (BS)
    PGY-2 Oncology Specialty Pharmacy: Audie L. Murphy Memorial VA Hospital, San Antonio, TX
    Precepts: Medical Oncology (Onc), Academia (Onc)

    Audrea Szabatura, PharmD, BCOP
    Medication Safety Officer
    Education: University of Connecticut
    PGY-1: Thomas Jefferson University Hospital, Philadelphia, PA
    PGY-2 Oncology: The Johns Hopkins Hospital, Baltimore, MD
    Precepts: Medication Safety (Onc)

    Victor Phantumvanit, PharmD, BCPS, BCOP
    Clinical Pharmacy Specialist
    Education: University of Maryland, School of Pharmacy, Baltimore, MD
    PGY-1: Central Washington Hospital, Wenatchee, WA
    PGY-2 Oncology & Palliative Care: Dana-Farber Cancer Institute, Boston, MA
    Precepts: Inpatient Palliative Care Unit (Onc and PMPC)

    Phuong Nguyen, PharmD
    Outpatient Pharmacy Manager
    Education: MCPHS University, Boston, MA
    Precepts: Outpatient Pharmacy Department (PMPC)

    Theresa LeFrancois, PharmD, BCOP
    Pediatric Oncology Clinical Pharmacist
    Education: MCPHS University, Boston, MA
    Precepts: Pediatrics (Onc)

    Inna Zinger, NP, AGPCNP-BC
    Adult Nurse Practitioner, Post-Operative Pain Service, Brigham and Women's Hospital
    Education: BSN, Northeastern University, Boston, MA; MSN, Northeastern University, Boston, MA
    Precepts: Post-Operative Pain Management Service (PMPC)

  • Current and Past Residents

    Current Residents

    2017-2018

    Oncology Pharmacy

    Elaine Xiang, PharmD
    PGY-1 Training: NYU Langone Medical Center, New York, NY     
    Education: Northeastern University
    elaine_xiang@dfci.harvard.edu

    Patrick McBride, PharmD
    PGY-1 Training: Children's Hospital of Wisconsin, Milwaukee, WI     
    Education: MCPHS University, Boston, MA     
    patrick_mcbride@dfci.harvard.edu

    Pain Management/Palliative Care

    Iman F. Suliman, PharmD
    PGY-1 Training: North Florida/South Georgia Veterans Health System    
    Education: University of Florida, Gainesville, FL     
    imanf_suliman@dfci.harvard.edu

    Past Residents

    2016-2017

    Oncology Pharmacy

    Huong (Heather) Truong, PharmD
    PGY-1: Yale New Haven Health system, New Haven, CT    
    Education: University of Connecticut School of Pharmacy
    Current Position: Inpatient Oncology Pharmacist, Mayo Clinic, Rochester, MN

    Mary Nauffal, PharmD, MS     
    PGY-1: Brigham and Women's Hospital, Boston, MA     
    Education: Lebanese American University, Beirut, Lebanon     
    Current Position: Inpatient Oncology Pharmacy Specialist, Brigham and Women's Hospital, Boston, MA

    Pain Management/Palliative Care

    Benjamin S. Kematick, PharmD
    PGY-1: University at Buffalo/Mobile Pharmacy Solutions, Buffalo, NY
    Education: University at Buffalo, Buffalo, NY
    Current Position: Clinical Pharmacy Specialist - Palliative Care, Dana-Farber Cancer Institute, Boston, MA

    2015-2016

    Jacob Barker, PharmD
    PGY-1: University of Michigan Health System, Ann Arbor, MI
    Education: University of New England School of Pharmacy, Portland, ME
    Current Position: Clinical Oncology Pharmacy Specialist, Roswell Park Cancer Institute, Buffalo, NY

    Sydney Smith, PharmD
    PGY-1: Cleveland Clinic, Cleveland, OH
    Education: Rosman University of Health Sciences, Henderson, NV
    Current Position: Stem Cell Transplant Clinical Pharmacist, Seattle Cancer Care Alliance, Seattle, WA

    2014-2015

    Doug Hackenyos, PharmD
    PGY-1: Tufts Medical Center, Boston, MA
    Education: MCPHS University, Worcester, MA
    Current Position: Clinical Pharmacy Specialist, Tufts New England Medical Center, Boston, MA

    Cynthia Herrera, PharmD
    PGY-1: Northwestern Memorial Hospital, Chicago, IL
    Education: Purdue University College of Pharmacy, West Lafayette, IN
    Current Position: Hematology/Oncology Clinical Pharmacist, Northwestern Medicine, Chicago, IL

    2013-2014

    Laura (Perry) Hackett, PharmD, BCOP     
    PGY-1: Dartmouth-Hitchcock Medical Center, Lebanon, NH
    Education: MCPHS University, Boston, MA
    Current Position: Hematology/Oncology Clinical Pharmacist, Dartmouth-Hitchcock Medical Center, Lebanon, NH

    Taylor Butler, PharmD, BCOP     
    PGY-1: Blount Memorial Hospital, Maryville, TN
    Education: University of Tennessee Health Science Center, Memphis and Knoxville, TN
    Current Position: Acute Care Clinical Pharmacist, Tennessee Valley Veterans Affairs Health System, Nashville, TN

    2012-2013

    Amanda Dietzek, PharmD
    PGY-1: Einstein Medical Center, Philadelphia, PA
    Education: Northeastern University, Boston, MA
    Current Position: Oncology Clinical Pharmacy Manager, Einstein at Center One Pharmacy, Philadelphia, PA

    Kelly Connelly, PharmD, BCOP     
    PGY-1: Mount Sinai Medical Center, New York, NY
    Education: Duquesne University, Mylan School of Pharmacy, Pittsburgh, PA
    Current Position: Clinical Pharmacy Specialist, Johns Hopkins Hospital, Baltimore, MD

    2011-2012

    Kelley Carlstrom, PharmD, BCOP
    PGY-1: Beth Israel Deaconess Medical Center, Boston, MA
    Education: University of Colorado, Denver College of Pharmacy, Denver, CO
    Current Position: Clinical Oncology Consultant, iMethods, Jacksonville, FL

    2010-2011

    Meredith W. H. Higley, PharmD, BCPS, BCOP
    PGY-1: Parkview Health, Fort Wayne, IN
    Education: MCPHS University, Boston, MA
    Current Position: Coordinator, Oncology Pharmacy Services, Berkshire Medical Center, Pittsfield, MA

    2009-2010

    Houry Leblebjian, PharmD, BCOP
    PGY-1: UMass Memorial Medical Center, Worcester, MA
    Education: Lebanese American University, West Beirut, Lebanon
    Current Position: Clinical Pharmacy Practice Administrator, Dana-Farber Cancer Institute, Boston, MA

    2008-2009

    Jian Ni, PharmD
    PGY-1: West Virginia University Hospital, Morgantown, WV
    Education: MCPHS University, Boston, MA
    Current Position: Inpatient Oncology Pharmacy Specialist, Brigham and Women's Hospital, Boston, MA

    2007-2008

    Delila Katz, PharmD, BCOP
    PGY-1: Boston Medical Center, Boston, MA
    Current Position: Clinical Pharmacy Specialist, Palliative Care Oncology, UMass Memorial Medical Center, Worcester, MA

    2006-2007

    Victor Phantumvanit, PharmD, BCPS, BCOP
    PGY-1: Central Washington Hospital, Wenatchee, WA
    Education: University of Maryland, School of Pharmacy
    Current Position: Clinical Pharmacy Specialist, Dana-Farber Cancer Institute, Boston, MA

    2005-2006

    Gayle Blouin, PharmD, BCOP
    Education: MCPHS University, Boston, MA
    Current Position: Clinical Lead Pharmacist Ambulatory Oncology, Massachusetts General Hospital, Boston, MA

  • Applying for the Pharmacy Residency

    Eligibility

    Interested applicants must have a PharmD degree and successfully complete an ASHP-accredited PGY-1 pharmacy residency prior to anticipated start date. Candidate must also be eligible for licensure in the Commonwealth of Massachusetts.

    Application procedure

    Please submit your application through PhORCAS (Pharmacy Online Residency Centralized Application Service) — portal.phorcas.org — including:

    • Letter of intent
    • Curriculum vitae
    • Three letters of recommendation

    Deadline for applying: Refer to PhORCAS
    Residency start date: First week in July